The kids may be sleeping soundly this season with “visions of sugar plums in their heads,” but almost half of the nation’s moms and dads (44%) say they are worried about being able to afford the holidays this year, with one in six Americans (17%) expecting to lose sleep due to holiday-induced stress. The findings are part of a national year-end survey – the SleepBetter.org Holiday Slumber Index, which measures the impact of the holidays on Americans’ sleep patterns.
Tripep (STO:TPEP) received the approval from the Swedish Medical Products Agency and the local ethical committee to give three patients in the highest dose group in the ChronVac-C® study one additional treatment with the therapeutic vaccine. All twelve patients in the study have earlier received four treatments with ChronVac-C® given at three different doses and one month apart
Hyperion Therapeutics, Inc. announced that the first patient has been enrolled in its phase II clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The multi-center study consists of an open label safety component followed by a randomized, double-blind, placebo-controlled study that will enroll approximately 140 patients with episodic hepatic encephalopathy in the US and Eastern Europe.
HealthMedia, Inc., a Johnson & Johnson company, introduced two new Digital Coaching™ programs that help lower cardiovascular disease risk for employee populations. HealthMedia® ACHIEVE™ and HealthMedia® CONTROL™ improve cholesterol and blood pressure self-management through comprehensive and scalable Digital Coaching™ that focuses on behavior change and personal motivation.
Loading ...